Abstract
Bioactive compounds are often used as initial substances for many therapeutic agents. In recent years, both theoretical and practical innovations in hardware-assisted and fast-evolving machine learning (ML) have made it possible to identify desired bioactive compounds in chemical spaces, such as those in natural products (NPs). This review introduces how machine learning approaches can be used for the identification and evaluation of bioactive compounds. It also provides an overview of recent research trends in machine learning-based prediction and the evaluation of bioactive compounds by listing real-world examples along with various input data. In addition, several ML-based approaches to identify specific bioactive compounds for cardiovascular and metabolic diseases are described. Overall, these approaches are important for the discovery of novel bioactive compounds and provide new insights into the machine learning basis for various traditional applications of bioactive compound-related research.
Funding Information
  • Korea Food Research Institute (E0210601-01)
  • National Research Foundation of Korea (NRF) grants funded by the Korean government (MSIT) (NRF-2019R1C1C1010385)
  • National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (1720100)
  • Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2020R1A6A1A03043283)
  • the Research-Focused Department Promotion Project as a part of the University Innovation Sup-port Program (Dankook University in 2021)

This publication has 92 references indexed in Scilit: